Close
In Drug Discovery Today: Advancing novel therapies for neurodegeneration through an innovative model
4 September 2023
September is World Alzheimer's Month, dedicated to raising awareness about dementia. We are thrilled to share the case study of the Eisai–UCL collaboration recently published in Drug Discovery Today.
The Eisai-UCL collaboration has been running since December 2012, spearheaded by the UCL Translational Research Office (TRO) and the Dean of Faculty Brain Sciences. Seven projects have been established and the first project, a novel anti-tau antibody for Alzheimer’s disease, has entered clinical trials.
The collaboration was set up to create a portfolio of novel therapeutics for neurodegenerative diseases. It also serves as an exemplar of how academia and industry can effectively work together.
<In Drug Discovery Today>
Advancing novel therapies for neurodegeneration through an innovative model for industry-academia collaborations: A decade of the Eisai–UCL experience
The article highlights:
- How a productive partnership brings together complementary expertise
- The challenges to setting up a productive collaboration
- The structure of the Eisai-UCL collaboration
- Outcomes of the collaboration after ten years
- Best practices and lessons from the Eisai-UCL experience
Read the full article here.
Read more:
- Eisai and UCL confirm an extension of the Drug Discovery and Development Collaboration Agreement
- UCL Eisai strategic alliance tackles Alzheimer's and Parkinson's
- UCL and Eisai celebrate 10 years of a strategic partnership to tackle neurodegenerative diseases
Links:
- UCL Faculty of Brain Sciences
- Queen Square Institute of Neurology
- Dementia Research Centre
- Eisai press release
- Eisai
- UCL Translational Research Office Business & Innovation Group
Interested to stay informed of upcoming news, events and funding calls?
- Subscribe to our newsletter and you would automatically become a member of UCL TINs (Therapeutic Innovation Networks) and be the first to receive our event invitations
- Follow us on social media (LinkedIn, Twitter) and stay tuned to our news and updates.
TRO has created an online, internal portal (UCL sign-in required) to showcase the breadth of biomedical expertise at UCL and our partner hospitals, aiming to facilitate multidisciplinary collaborations and capabilities mapping.
- Input your profile to get your capabilities visible across UCL experts and potentially external partners facilitated by TRO, leading to collaboration and funding opportunities.